The cure to Parkinson’s Disease might now be available
19 Mar 2019
In a new study, the researchers at University of Bristol tested whether Glial Cell Line Derived Neurotrophic Factor (GDNF) have the ability to regenerate dying dopamine brain cells in patients with Parkinson’s and reverse their condition.
While Parkinson’s is caused by the destruction of dopamine in the brain, scientists have sizable evidence that a reawakening and reinforcement of the cells. This was proven by an experiment wherein GDNF or placebo was infused directly into the brain at the exact same location where the cells were absent. The results were surprisingly positive and hence the relevance and usefulness of GDNF came to light. Scientists look towards developing on this breakthrough to start full treatment of the Parkinson’s disease soon.